ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2232

A Role for CCR2 in Chronic Behavioral and Neuroimmune Changes in the DMM Model of Osteoarthritis

Phuong Tran1, Shingo Ishihara2, Rachel E. Miller3, Richard J. Miller4 and Anne-Marie Malfait1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Internal Medicine, Rush University Medical Center, Chicago, IL, 3Biochemistry, Rush University Medical Center, Chicago, IL, 4Pharmacology/Medical Humanities and Bioethics, Northwestern University, Chicago, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Chemokine Receptors, Macrophage, Mouse model, osteoarthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Pain – Basic and Clinical Aspects Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The aim of this study was to explore pain-related behaviors and associated cellular changes in the pain pathway in experimental osteoarthritis (OA) induced by destabilization of the medial meniscus (DMM). In wild-type (WT) mice, DMM results in slowly progressive knee OA, associated with pain behaviors, including mechanical allodynia and decreased locomotion. We have previously reported that CCR2 signaling is a key mediator for persistence of pain after DMM. Specifically, 8 weeks after DMM, L3-L5 dorsal root ganglia (DRG) neurons show increased expression of CCR2 gene and protein. Ccr2 null mice develop initial mechanical allodynia following DMM, but the allodynia is not maintained (unlike in WT mice). WT and Ccr2null mice develop the same extent of joint damage after DMM.

Methods: DMM or sham surgery was performed in the right knees of 10-week old male WT or Ccr2 null C57BL/6 mice. The elevated plus maze was employed as a method for assessing anxiety-related responses (time spent grooming; time spent immobile) over a period of 5 minutes. To assess cellular changes in the peripheral and central nervous system, we quantified (1) macrophages in the L4 DRG, by immunostaining for F4/80 and (2) activated microglia in the L4 dorsal horn of the spinal cord, based on the morphology of Iba1-immunoreactive microglia, using established methods.

Results: Eight weeks after sham or DMM surgery, WT mice showed no behavioral changes in the elevated maze plus test. However, by 16 weeks after surgery, DMM (but not sham) operated mice showed behaviors indicative of anxiety, including increased periods of immobility (p=0.002, n=5-13) and increased time spent grooming (p=0.0073, n=6-15). These behaviors did not develop in Ccr2 null mice (p>0.9, n=8-14).

In WT mice, L4 DRG were strongly infiltrated with F4/80 expressing macrophages, 8 and 16 weeks after DMM. In contrast, in Ccr2 null mice, L4 DRG showed some macrophage infiltration at 8 weeks, but to a lesser extent than in WT mice. Furthermore, in Ccr2 null mice, F4/80 levels returned to baseline by week 16. The L4 dorsal horn in WT mice showed a clearly increased number of activated microglia 8 and 16 weeks after DMM but not sham surgery (wk 8: p=0.015; wk 16: p=0.039, n=3-6/group/time point). In Ccr2 null mice, activated microglia were increased 8 wks after DMM compared to baseline (p<0.05, n = 3-9/group/time point), but this returned to baseline by week 16.

Conclusion: We describe a novel behavior that specifically develops during the chronic stage of the DMM model: increased grooming, which is considered an indicator of anxiety. Increased grooming may be indicative of pain-related anxiety, since it coincides with the chronic pain phase of the disease. Ccr2 null mice did not develop this grooming behavior, confirming our previous findings that these mice do not develop chronic pain after DMM. Overall, these data support our previous work suggesting that CCR2 activation is important in the maintenance of chronic OA pain, perhaps by mediating neuro-immune interactions in both the DRG and the spinal cord. The fact that Ccr2 null mice developed initial macrophage infiltration and microgliosis that subsequently resolved suggests that these pathways may be targetable.


Disclosure: P. Tran, None; S. Ishihara, None; R. E. Miller, None; R. J. Miller, None; A. M. Malfait, Galapagos, Regeneron, 5,Ferring, 2,OARSI board of directors, 6.

To cite this abstract in AMA style:

Tran P, Ishihara S, Miller RE, Miller RJ, Malfait AM. A Role for CCR2 in Chronic Behavioral and Neuroimmune Changes in the DMM Model of Osteoarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-role-for-ccr2-in-chronic-behavioral-and-neuroimmune-changes-in-the-dmm-model-of-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-role-for-ccr2-in-chronic-behavioral-and-neuroimmune-changes-in-the-dmm-model-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology